SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950123-10-085559
Filing Date
2010-09-13
Accepted
2010-09-13 11:34:34
Documents
3
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D b82649sc13d.htm SC 13D 92830
2 EX-99.1 b82649exv99w1.htm EX-99.1 7189
3 EX-99.2 b82649exv99w2.htm EX-99.2 24472
  Complete submission text file 0000950123-10-085559.txt   126541
Mailing Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121
Business Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121 8584522323
CYPRESS BIOSCIENCE INC (Subject) CIK: 0000716054 (see all company filings)

IRS No.: 222389839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-35589 | Film No.: 101068565
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 PARK PLAZA, SUITE 905 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 905 BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D